Predicting mortality rate in elderly patients operated for hip fracture using red blood cell distribution width, neutrophil-to-lymphocyte ratio, and Nottingham Hip Fracture Score
Joint Diseases and Related Surgery · 01.12.2022 · 33 (3) · 538-546
DOI: 10.52312/jdrs.2022.683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Joint Diseases and Related Surgery, online erschienen am 06.10.2022. Verfasst von Selami Karadeniz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Samsun Eğitim ve Araştırma Hastanesi Ortopedi ve Travmatoloji Kliniği, 55090 İlkadım, Samsun, Türkiye. yurtbayalparslan@gmail.com. Hauptthemen laut MEDLINE: Hip Fractures, Femoral Neck Fractures. Die Arbeit wurde bisher 20-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Samsun Eğitim ve Araştırma Hastanesi Ortopedi ve Travmatoloji Kliniği, 55090 İlkadım, Samsun, Türkiye. yurtbayalparslan@gmail.com.
Zitieren
APA
Karadeniz, S., & Yurtbay, A. (2022). Predicting mortality rate in elderly patients operated for hip fracture using red blood cell distribution width, neutrophil-to-lymphocyte ratio, and Nottingham Hip Fracture Score. Joint Diseases and Related Surgery, 33(3), 538-546. https://doi.org/10.52312/jdrs.2022.683
Vancouver
Karadeniz S, Yurtbay A. Predicting mortality rate in elderly patients operated for hip fracture using red blood cell distribution width, neutrophil-to-lymphocyte ratio, and Nottingham Hip Fracture Score. Joint Diseases and Related Surgery. 2022;33(3):538-546. doi:10.52312/jdrs.2022.683
BibTeX
@article{Karadeniz2022,
author = {Karadeniz, Selami and Yurtbay, Alparslan},
title = {Predicting mortality rate in elderly patients operated for hip fracture using red blood cell distribution width, neutrophil-to-lymphocyte ratio, and Nottingham Hip Fracture Score},
journal = {Joint Diseases and Related Surgery},
year = {2022},
volume = {33},
number = {3},
pages = {538--546},
doi = {10.52312/jdrs.2022.683}
}
EUVIMED